Chapter 9. Cardiovascular Toxicities of NSAIDS: Epidemiologic Aspects

  1. Giorgio Minotti
  1. Antonio González-Pérez1,2 and
  2. Luis Alberto García Rodriguez1

Published Online: 9 APR 2010

DOI: 10.1002/9780470660379.ch9

Cardiotoxicity of Non-Cardiovascular Drugs

Cardiotoxicity of Non-Cardiovascular Drugs

How to Cite

González-Pérez, A. and García Rodriguez, L. A. (2010) Cardiovascular Toxicities of NSAIDS: Epidemiologic Aspects, in Cardiotoxicity of Non-Cardiovascular Drugs (ed G. Minotti), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470660379.ch9

Editor Information

  1. University Campus Bio-Medico, CIR and Drug Sciences, and Alberto Sordi Foundation-Research Institute on Aging, Via Alvaro del Portillo 21, 00128 Rome, Italy

Author Information

  1. 1

    Centro Espan˜ ol de Investigación Farmacoepidemiológica (CEIFE), Almirante 28, 2°, 28004 Madrid, Spain

  2. 2

    Departamento de Genética Estructural. NeoCodex SL, Charles Darwin 6, 41092 Sevilla, Spain

Publication History

  1. Published Online: 9 APR 2010
  2. Published Print: 16 APR 2010

ISBN Information

Print ISBN: 9780470772744

Online ISBN: 9780470660379

SEARCH

Keywords:

  • NSAIDs cardiovascular toxicities - epidemiologic aspects;
  • ASA - acetyl salicylic acid - aspirin;
  • NSAIDs and gastrointestinal (GI) safety - COX-2 inhibition;
  • NSAIDs pharmacology - cardiovascular toxicity;
  • relative risk (RR) estimation - NSAID-related cardiotoxicity studies;
  • NSAID use, duration - NSAID-related cardiotoxic effect analysis;
  • traditional NSAID-ASA co-administration - cardioprotection loss

Summary

This chapter contains sections titled:

  • Introduction

  • Pharmacology

  • Risk Estimate (Magnitude of the Problem)

  • Duration

  • Interaction

  • Conclusions

  • References